Attached files

file filename
8-K - FORM 8-K - TERADYNE, INCd8k.htm

Exhibit 99.1

Teradyne Reports 22 Percent Sequential Increase in First Quarter Sales; Orders Grow 30 Percent

 

   

Q1’11 revenue of $377 million, up 22% from Q4’10 and up 18% from Q1’10

 

   

Q1’11 diluted non-GAAP income from continuing operations of $0.39 per share, up from $0.35 per share in Q4’10 and up from $0.33 per share in Q1’10; Q1’11 diluted GAAP income from continuing operations of $0.29 per share

 

   

Q2’11 guidance: Revenue of $375 million to $400 million; Diluted non-GAAP income from continuing operations of $0.38 to $0.44 per share; Diluted GAAP income from continuing operations of $0.28 to $0.34 per share

NORTH READING, Mass. – April 27, 2011 – Teradyne, Inc. (NYSE: TER) reported revenue of $377 million for the first quarter of 2011 of which $319 million was in Semiconductor Test and $58 million in Systems Test Group. On a non-GAAP basis, Teradyne’s income from continuing operations in the first quarter was $78.7 million, or $0.39 per diluted share, which excluded acquired intangible asset amortization, non-cash convertible debt interest and restructuring and other charges. GAAP income from continuing operations for the first quarter was $68.1 million, or $0.29 per diluted share.

Bookings in the first quarter of 2011 were $435 million of which $360 million were in Semiconductor Test and $75 million in the Systems Test Group.

Guidance for the second quarter of 2011 is for revenue of $375 million to $400 million, with non-GAAP income from continuing operations per diluted share of $0.38 to $0.44 and GAAP income from continuing operations per diluted share of $0.28 to $0.34. Non-GAAP guidance excludes acquired intangible asset amortization, non-cash convertible debt interest and restructuring and other charges.

“2011 is off to a strong start as we delivered our fifth quarter of above model performance driven by solid sales growth in our semiconductor and systems test groups,” said Mike Bradley, Teradyne President and CEO. “Total orders were up 30% as our customers expand their test capacity to meet growing end market demand for a broad range of products including smart phones, tablets, automobiles and data storage.”

Webcast

A conference call to discuss the first quarter 2011 results, along with management’s business outlook is scheduled at 10 a.m. EDT, Thursday, April 28. The call will be broadcast simultaneously over the Internet. Interested investors should access the webcast at www.teradyne.com and click on “Investors” at least five minutes before the call begins.

A replay will be available approximately two hours after the completion of the call. The replay number in the U.S. & Canada is 800-642-1687. The replay number outside the U.S. & Canada is 706-645-9291. The pass code for both numbers is 60384737. A replay will also be available on the Teradyne website www.teradyne.com. Click on “Investors” for a link to the replay. The replay will be available via phone and website through May 14, 2011.


Page 2

Non-GAAP Results

In addition to disclosing results that are determined in accordance with GAAP, Teradyne also discloses non-GAAP results of operations that exclude certain income items and charges. These results are provided as a complement to results provided in accordance with GAAP. Non-GAAP income from operations and non-GAAP income from continuing operations exclude acquired intangible asset amortization, non- cash convertible debt interest, and restructuring and other, net. GAAP requires that these items be included in determining income from operations and income from continuing operations. Non-GAAP income from operations, non-GAAP income from continuing operations, non-GAAP income from operations and non-GAAP income from continuing operations as a percentage of revenue, and non-GAAP income from continuing operations per share are non-GAAP measures presented to provide meaningful supplemental information regarding Teradyne’s baseline performance before gains, losses or other charges that may not be indicative of Teradyne’s current core business or future outlook. These non-GAAP measures are used to make operational decisions, to determine employee compensation, to forecast future operational results, and for comparison with Teradyne’s business plan, historical operating results and the operating results of Teradyne’s competitors. Non-GAAP diluted shares include the impact of Teradyne’s call option on its shares. Management believes each of these non-GAAP measures provides useful supplemental information for investors, allowing greater transparency to the information used by management in its operational decision making and in the review of Teradyne’s financial and operational performance, as well as facilitating meaningful comparisons of Teradyne’s results in the current period compared with those in prior and future periods. A reconciliation of each available GAAP to non-GAAP financial measure discussed in this press release is contained in the attached exhibits and on the Teradyne website at www.teradyne.com by clicking on “Investors” and then selecting the “GAAP to Non-GAAP Reconciliation” link. The presentation of non-GAAP measures is not meant to be considered in isolation, as a substitute for, or superior to, financial measures or information provided in accordance with GAAP.

About Teradyne

Teradyne (NYSE:TER) is the leading supplier of Automatic Test Equipment used to test complex electronics used in the consumer electronics, automotive, computing, telecommunications, and aerospace and defense industries. Teradyne had 2010 sales of $1.6 billion and employs about 2,900 people worldwide. For more information, visit www.teradyne.com. Teradyne(R) is a registered trademark of Teradyne, Inc. in the U.S. and other countries.

Safe Harbor Statement

This release contains forward-looking statements regarding future business prospects, Teradyne’s results of operations and market conditions. Such statements are based on the current assumptions and expectations of Teradyne’s management and are neither promises nor guarantees of future performance. You can identify these forward-looking statements based on the context of the statements and by the fact that they use words such as “will,” “anticipate,” “expect,” “project,” “intend,” “plan,” “believe,” “target” and other words and terms of similar meaning in connection with any discussion of future operating or financial performance. There can be no assurance that management’s estimates of Teradyne’s future results or other forward looking statements will be achieved. Important factors that could cause actual results to differ materially from those presently expected include: conditions affecting the markets in which Teradyne operates; decreased or delayed product demand; increased competition in certain markets resulting from the announced merger of Advantest and Verigy; and other events, factors and risks disclosed in filings with the SEC, including, but not limited to, the “Risk Factors” section of Teradyne’s Annual Report on Form 10-K for the fiscal year ended December 31, 2010. The forward-looking statements provided by Teradyne in this press release represent management’s views as of the date of this release. Teradyne anticipates that subsequent events and developments may cause management’s views to change. However, while Teradyne may elect to update these forward-looking statements at some point in the future, Teradyne specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Teradyne’s views as of any date subsequent to the date of this release.


TERADYNE, INC. REPORT FOR FIRST FISCAL QUARTER OF 2011

 

 

CONDENSED CONSOLIDATED OPERATING STATEMENTS

    (In thousands, except per share amounts)

 

 

     Quarter Ended  
     April 3, 2011     December 31, 2010     April 4, 2010  

Net Revenues

   $ 377,161      $ 310,162      $ 319,338   

Cost of Revenues (1)

     184,752        146,773        149,461   
                        

Gross Profit

     192,409        163,389        169,877   

Operating Expenses:

      

Engineering and Development

     47,977        46,691        47,937   

Selling and Administrative

     58,229        53,843        54,686   

Acquired Intangible Asset Amortization

     7,291        7,291        7,356   

Restructuring and Other, net (2)

     413        (114     904   
                        

Operating Expenses

     113,910        107,711        110,883   

Income from Operations

     78,499        55,678        58,994   

Interest & Other (3)

     (4,889     (4,884     (5,065
                        

Income from Continuing Operations Before Income Taxes

     73,610        50,794        53,929   

Income Tax Provision (Benefit)

     5,486        (6,405     4,830   
                        

Income from Continuing Operations

     68,124        57,199        49,099   

Income from Discontinued Operations Before Income Taxes (4)

     1,278        3,080        1,001   

Income Tax (Benefit) Provision

     (267     138        —     
                        

Income from Discontinued Operations

     1,545        2,942        1,001   

Gain on Disposal of Discontinued Operations (net of income tax provision of $4,578)

     25,203        —          —     
                        

Net Income

   $ 94,872      $ 60,141      $ 50,100   
                        
Income per Common Share from Continuing Operations:       

Basic

   $ 0.37      $ 0.31      $ 0.28   
                        

Diluted

   $ 0.29      $ 0.26      $ 0.24   
                        
Net Income per Common Share:       

Basic

   $ 0.51      $ 0.33      $ 0.28   
                        

Diluted

   $ 0.41      $ 0.27      $ 0.24   
                        

Weighted Average Common Shares - Basic

     184,720        181,600        176,867   
                        

Weighted Average Common Shares - Diluted (5)

     232,080        220,023        226,277   
                        

Net Orders

   $ 435,077      $ 334,129      $ 522,812   
                        
(1)    Cost of Revenues includes:    Quarter Ended  
     April 3, 2011     December 31, 2010     April 4, 2010  

Sale of Previously Written Down Inventory

   $ (3,022   $ (1,421   $ —     

Provision for Excess and Obsolete Inventory

     4,627        790        1,177   
                        
   $ 1,605      $ (631   $ 1,177   
                        
(2)    Restructuring and Other, net consists of:    Quarter Ended  
     April 3, 2011     December 31, 2010     April 4, 2010  

Employee Severance

   $ 844      $ 191      $ 904   

Facility Related

     (431     (305     —     
                        
   $ 413      $ (114   $ 904   
                        
(3)    Interest & Other includes:    Quarter Ended  
     April 3, 2011     December 31, 2010     April 4, 2010  

Non-Cash Convertible Debt Interest

   $ 2,858      $ 2,762      $ 2,494   

 

(4) On March 21, 2011, Teradyne completed the sale of its Diagnostic Solutions business unit to SPX Corporation for a gain of $25.2 million. The results for the discontinued business unit have been included within discontinued operations for all periods presented.

 

(5) Under GAAP, when calculating diluted earnings per share, convertible debt must be assumed to have converted if the effect on EPS would be dilutive. Diluted shares assume the conversion of the convertible debt as the effect would be dilutive. Accordingly, for the quarters ended April 3, 2011, December 31, 2010 and April 4, 2010, 23.4 million, 19.3 million and 34.7 million shares, respectively, have been included in diluted shares and net interest expense of $0, $0 and $4.4 million, respectively, has been added back to income from continuing operations and net income for the diluted earnings per share calculations.


CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands)

 

 

     April 3, 2011      December 31, 2010  

Assets

     

Cash and Cash Equivalents

   $ 420,267       $ 397,737   

Marketable Securities

     435,575         409,061   

Accounts Receivable

     186,254         168,756   

Inventories

     129,692         116,841   

Deferred Tax Assets

     22,634         22,730   

Prepayments and Other Current Assets

     56,375         52,780   

Current Assets from Discontinued Operations (1)

     —           8,713   
                 

Total Current Assets

     1,250,797         1,176,618   

Net Property, Plant and Equipment

     232,969         231,108   

Long-Term Marketable Securities

     244,466         248,696   

Retirement Plan Assets

     14,345         13,981   

Intangible Assets

     115,649         122,941   

Other Assets

     16,472         16,542   

Long-Term Assets from Discontinued Operations (1)

     —           469   
                 

Total Assets

   $ 1,874,698       $ 1,810,355   
                 

Liabilities

     

Accounts Payable

   $ 109,988       $ 81,142   

Accrued Employees’ Compensation and Withholdings

     62,036         105,374   

Deferred Revenue and Customer Advances

     94,216         105,568   

Other Accrued Liabilities

     56,613         57,145   

Accrued Income Taxes

     8,199         8,465   

Current Debt

     2,417         2,450   

Current Liabilities from Discontinued Operations (1)

     —           3,560   
                 

Total Current Liabilities

     333,469         363,704   

Long-Term Deferred Revenue and Customer Advances

     58,357         71,558   

Retirement Plan Liabilities

     74,435         72,071   

Deferred Tax Liabilities

     9,756         9,849   

Other Long-Term Liabilities

     19,501         19,448   

Long-Term Debt

     151,748         150,182   

Long-Term Liabilities from Discontinued Operations (1)

     —           1,355   
                 

Total Liabilities

     647,266         688,167   

Shareholders’ Equity

     1,227,432         1,122,188   
                 

Total Liabilities and Shareholders’ Equity

   $ 1,874,698       $ 1,810,355   
                 

 

(1)

On March 21, 2011, Teradyne completed the sale of its Diagnostic Solutions business unit to SPX Corporation. The assets and liabilities of the discontinued business unit have been included within discontinued operations at December 31, 2010.


CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands)

 

 

     Quarter Ended  
     April 3, 2011     April 4, 2010  

Cash flows from operating activities:

    

Net income

   $ 94,872      $ 50,100   

Less: Income from discontinued operations

     1,545        1,001   

Less: Gain on disposal of discontinued operations

     25,203        —     
                

Income from continuing operations

     68,124        49,099   

Adjustments to reconcile income from continuing operations to net cash provided by operating activities:

    

Depreciation

     13,057        13,195   

Amortization

     12,442        11,935   

Stock-based compensation

     7,464        7,973   

Provision for excess and obsolete inventory

     4,627        1,177   

Other

     618        709   

Changes in operating assets and liabilities, net of businesses sold:

    

Accounts receivable

     (17,498     (53,865

Inventories

     (10,709     16,384   

Other assets

     (2,540     20,066   

Deferred revenue and customer advances

     (24,553     (35,414

Accounts payable and accrued expenses

     (26,014     243   

Retirement plan contributions

     (1,176     (6,659

Accrued income taxes

     (4,577     —     
                

Net cash provided by continuing operations

     19,265        24,843   

Net cash provided by discontinued operations

     353        1,243   
                

Net cash provided by operating activities

     19,618        26,086   

Cash flows from investing activities:

    

Purchases of property, plant and equipment

     (22,131     (17,587

Purchases of available-for-sale marketable securities

     (211,289     (95,399

Proceeds from sales of available-for-sale marketable securities

     188,448        7,069   

Proceeds from sales of trading marketable securities

     —          150   
                

Net cash used for continuing operations

     (44,972     (105,767

Net cash provided by discontinued operations

     39,030        —     
                

Net cash used by investing activities

     (5,942     (105,767

Cash flows from financing activities:

    

Issuance of common stock

     10,076        6,079   

Payments of long-term debt

     (1,222     (1,123
                

Net cash provided by continuing operations

     8,854        4,956   

Net cash provided by discontinued operations

     —          —     
                

Net cash provided by financing activities

     8,854        4,956   

Increase (decrease) in cash and cash equivalents

     22,530        (74,725

Cash and cash equivalents at beginning of period

     397,737        416,737   
                

Cash and cash equivalents at end of period

   $ 420,267      $ 342,012   
                


GAAP to Non-GAAP Earnings Reconciliation

(In millions, except per share amounts)

 

    Quarter Ended  
    April 3, 2011     % of Net
Revenues
                December 31,
2010
    % of Net
Revenues
                April 4, 2010     % of Net
Revenues
             

Net Revenues

  $ 377.2            $ 310.2            $ 319.3         

Income from Operations - GAAP

  $ 78.5        20.8       $ 55.7        18.0       $ 59.0        18.5    

Acquired intangible asset amortization

    7.3        1.9         7.3        2.4         7.4        2.3    

Restructuring and other, net (1)

    0.4        0.1         (0.1     0.0         0.9        0.3    
                                                           

Income from Operations - non-GAAP

  $ 86.2        22.9       $ 62.9        20.3       $ 67.3        21.1    
                                                           
                Income per
Common
Share from
Continuing
Operations
                Income per
Common
Share from
Continuing
Operations
                Income per
Common
Share from
Continuing
Operations
 
    April 3, 2011     % of Net
Revenues
    Basic     Diluted     December 31,
2010
    % of Net
Revenues
    Basic     Diluted     April 4, 2010     % of Net
Revenues
    Basic     Diluted  

Income from Continuing Operations - GAAP

  $ 68.1        18.1   $ 0.37      $ 0.29      $ 57.2        18.4   $ 0.31      $ 0.26      $ 49.1        15.4   $ 0.28      $ 0.24   

Acquired intangible asset amortization

    7.3        1.9     0.04        0.03        7.3        2.4     0.04        0.04        7.4        2.3     0.04        0.04   

Restructuring and other, net (1)

    0.4        0.1     —          —          (0.1     0.0     —          —          0.9        0.3     0.01        —     

Convertible share adjustment (2)

    —          —          —          0.05        —          —          —          0.04        —          —          —          0.03   

Interest and other (3)

    2.9        0.8     0.02        0.01        2.8        0.9     0.02        0.01        2.5        0.8     0.01        0.01   
                                                                                               

Income from Continuing Operations - non-GAAP

  $ 78.7        20.9   $ 0.43      $ 0.39      $ 67.2        21.7   $ 0.37      $ 0.35      $ 59.9        18.8   $ 0.34      $ 0.33   
                                                                                               

GAAP and Non-GAAP Weighted Average Common Shares - Basic

    184.7              181.6              176.9         

GAAP Weighted Average Common Shares - Diluted

    232.1              220.0              226.3         

Exclude dilutive shares from convertible note

    (23.4           (19.3           (34.7      
                                         

Non-GAAP Weighted Average Common Shares - Diluted (2)

    208.7              200.7              191.6         
                                         

 

(1)    Restructuring and other, net consists of (in millions):

       

    Quarter Ended  
    April 3, 2011                       December 31,
2010
                      April 4, 2010                    

Employee Severance

  $ 0.8            $ 0.2            $ 0.9         

Facility Related

    (0.4           (0.3           —           
                                         
  $ 0.4            $ (0.1         $ 0.9         
                                         

 

(2) For the quarters ended April 3, 2011, December 31, 2010 and April 4, 2010, the calculation of non-GAAP diluted earnings per share gives benefit to the Company’s call option on its stock for 34.7 million shares at $5.48. As a result, 18.8 million, 13.1 million and 9.1 million shares, respectively, have been included in non-GAAP diluted shares and net interest expense of $2.4 million has been added back to non-GAAP income from continuing operations for the non-GAAP diluted earnings per share calculation.

 

(3) For the quarters ended April 3, 2011, December 31, 2010 and April 4, 2010, Interest and Other included non-cash convertible debt interest.

GAAP to Non-GAAP Reconciliation of Second Quarter 2011 guidance:

 

GAAP and Non-GAAP second quarter revenue guidance:

   $ 375 million       to   $ 400 million   

GAAP income from continuing operations per diluted share

   $ 0.28       $ 0.34   

Exclude acquired intangible asset amortization

   $ 0.03       $ 0.03   

Exclude non-cash convertible debt interest

   $ 0.01       $ 0.01   

Exclude dilutive shares from convertible note

   $ 0.06       $ 0.06   
                 

Non-GAAP income from continuing operations per diluted share

   $ 0.38       $ 0.44   

For press releases and other information of interest to investors, please visit Teradyne’s homepage at http://www.teradyne.com.

Contact:    Teradyne, Inc.
   Andy Blanchard 978-370-2425
   Vice President of Corporate Relations